BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Fomepizole

A pyrazole and competitive inhibitor of ALCOHOL DEHYDROGENASE that is used for the treatment of poisoning by ETHYLENE GLYCOL or METHANOL.

298+ PubMed studies analyzed · 4 RCTs · Evidence Score: 44.6

Research Domains

Fomepizole has been studied across 12 research domains including 🫘 Kidney, 🫁 Liver & Detox, 💊 Pain, 🧠 Focus & Attention, 🧘 Stress & Anxiety. The primary research focus is 🫘 Kidney with 34% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Fomepizole, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Galactitol
2 shared targets
Carbutamide
2 shared targets
Pyrrolidonecarboxylic
2 shared targets
Carduus
2 shared targets
Buthionine
2 shared targets
Pyridoxine
2 shared targets
pipemidic
2 shared targets
sulfameter
2 shared targets
Fluvastatin
2 shared targets
Tobramycin
2 shared targets
Loading evidence profile...

This evidence profile for Fomepizole is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.